Crestchem Limited (BOM:526269)
India · Delayed Price · Currency is INR 138.85
-8.65 (-5.86%)
At close: Oct 1, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 416.55 million as of October 2, 2026. Its market cap has increased by 5.59% in one year.
Market Cap
416.55M
Enterprise Value
412.75M
Revenue
338.33M
Ranking
n/a
PE Ratio
12.59
Stock Price
138.85
ChartMarket Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 416.55M, an increase of 1,233.81%. That is a compound annual growth rate of 20.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 416.55M | 23.48% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.51B |
| Auro Laboratories | 1.47B |
| Panchsheel Organics | 1.38B |
| Krebs Biochemicals & Industries | 1.27B |
| Tyche Industries | 1.07B |
| Vasundhara Rasayans | 478.64M |
| Alfavision Overseas (India) | 402.90M |
| Bacil Pharma | 394.56M |